Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Yu Mei Hsueh, Ying Chin Lin, Wei Jen Chen, Chao Yuan Huang, Horng Sheng Shiue, Yeong Shiau Pu, Chi Hung Chen, Chien Tien Su*

*此作品的通信作者

研究成果: 期刊稿件評論/辯論

摘要

Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “ e ” of Dr. Ying-Chin Lin, which was incorrectly given as. “ e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “ e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

原文英語
頁(從 - 到)139
頁數1
期刊Toxicology and Applied Pharmacology
356
DOIs
出版狀態已出版 - 01 10 2018

文獻附註

Publisher Copyright:
© 2018 Elsevier Inc.

指紋

深入研究「Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))」主題。共同形成了獨特的指紋。

引用此